Is it safe to use GS-441524 for FIP?

Is it safe to use GS-441524 for FIP?

These questions and answers about using GS-441524 come from the FaceBook page FIP Warriors using GS. While this is a closed group, they welcome anyone who faces FIP and wants to explore the use of the only available source of GS-441524 today. While these drugs are unregulated by any governmental agency, they are proving effective at treating FIP

Are there any FDA approved drugs for FIP?

FIP progress to date included initial, successful clinical trials using experimental drugs GC376 and GS441524. Both drugs are still experimental and neither approved or available to the general public. Additional FIP clinical trials using GC376 are underway, and GS441524/GS5734 is a human drug currently in a phase 2 clinical study.

Who has the legal right to GS-441524?

The patent is granted worldwide and encompasses additional chemical compounds for the same purpose (FCoV, FIPv, and FIP methods of treatment). So that is it, folks. GS-441524 is the joint property of Gilead Sciences, Inc. and The Regents of the University of California.

How long does it take for FIP to clear up?

A: Recommended treatment based on Dr. Pedersen’s original field trial is a minimum of 12 weeks of daily sub-cutaneous injections. Bloodwork should be checked at the end of 12 weeks and cat’s symptoms should be assessed to see if additional treatment is needed.

These questions and answers about using GS-441524 come from the FaceBook page FIP Warriors using GS. While this is a closed group, they welcome anyone who faces FIP and wants to explore the use of the only available source of GS-441524 today. While these drugs are unregulated by any governmental agency, they are proving effective at treating FIP

FIP progress to date included initial, successful clinical trials using experimental drugs GC376 and GS441524. Both drugs are still experimental and neither approved or available to the general public. Additional FIP clinical trials using GC376 are underway, and GS441524/GS5734 is a human drug currently in a phase 2 clinical study.

The patent is granted worldwide and encompasses additional chemical compounds for the same purpose (FCoV, FIPv, and FIP methods of treatment). So that is it, folks. GS-441524 is the joint property of Gilead Sciences, Inc. and The Regents of the University of California.

A: Recommended treatment based on Dr. Pedersen’s original field trial is a minimum of 12 weeks of daily sub-cutaneous injections. Bloodwork should be checked at the end of 12 weeks and cat’s symptoms should be assessed to see if additional treatment is needed.